Comparative performance of 11C-methionine and 11C-choline PET/CT in primary hyperparathyroidism: Impact of adenoma weight on PET detectability
European Journal of Nuclear Medicine and Molecular Imaging · 2026-11 · 53 (13) · 7982-7991
DOI: 10.1007/s00259-026-08116-6 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 14.08.2026. Verfasst von Laura García Belaustegui und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Clínica Universidad de Navarra, Madrid, Spain. Hauptthemen laut MEDLINE: Choline, Methionine, Positron Emission Tomography Computed Tomography, Hyperparathyroidism, Primary. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de Navarra.
Abstract (Originalsprache)
Purpose
To evaluate the diagnostic performance of [¹¹C]methionine (MET) PET/CT for preoperative localisation in primary hyperparathyroidism (PHPT) with negative or inconclusive first-line imaging, and to compare it with [¹¹C]choline (CHO) PET/CT in a head-to-head analysis, focusing on determinants of adenoma detectability.
Methods
Fifty-one patients with biochemically confirmed PHPT underwent MET PET/CT following inconclusive conventional imaging. In a subgroup of 25 patients, CHO PET/CT was also performed. Imaging findings were correlated with surgical and histopathological results. Detection rates and positive predictive values (PPV) were calculated, and semiquantitative parameters, including standardized uptake value (SUV) and lesion-to-background ratio (LBR), were analysed. Associations between PET findings, biochemical markers, and adenoma weight were explored.
Results
MET PET/CT achieved a patient-based detection rate of 76.5% with a PPV of 88.2%. In the head-to-head subgroup, CHO detected more lesions than MET (27 vs. 14; p = 0.0025) and identified all histologically confirmed adenomas, with comparable PPVs (90.0% vs. 77.8%). CHO demonstrated significantly higher SUV and LBR values. Adenoma weight was significantly associated with PET findings: MET-positive adenomas were significantly heavier than MET-negative adenomas, whereas CHO maintained high lesion detection even in adenomas weighing 0.5 g or less. Additionally, a trend towards higher uptake with increasing PTH and calcium levels was observed for CHO SUVmax.
Conclusion
Adenoma weight appears to be a major determinant of PET detectability in PHPT. The ability of CHO PET/CT to detect adenomas weighing 0.5 g or less, which may remain occult on MET, provides a plausible explanation for its superior lesion detection, while both tracers maintain a high positive predictive value. These findings further support the use of choline-based PET imaging in patients with inconclusive first-line studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Clínica Universidad de Navarra, Madrid, Spain.
- Department of Endocrinology, Clínica Universidad de Navarra, Madrid, Spain. mhiguera@unav.es.
- Department of Otorhinolaryngology, Clínica Universidad de Navarra, Madrid, Spain.
Förderung
- Universidad de Navarra
Zitieren
APA
García Belaustegui, L., de la Higuera López-Frías, M., de Abajo-Larriba, J., Basanta Mota, A., Bastidas, J. F., Morales Lozano, M. I., Grissanti, F., & Arbizu, J. (2026). Comparative performance of 11C-methionine and 11C-choline PET/CT in primary hyperparathyroidism: Impact of adenoma weight on PET detectability. European Journal of Nuclear Medicine and Molecular Imaging, 53(13), 7982-7991. https://doi.org/10.1007/s00259-026-08116-6
Vancouver
García Belaustegui L, de la Higuera López-Frías M, de Abajo-Larriba J, Basanta Mota A, Bastidas JF, Morales Lozano MI, et al. Comparative performance of 11C-methionine and 11C-choline PET/CT in primary hyperparathyroidism: Impact of adenoma weight on PET detectability. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(13):7982-7991. doi:10.1007/s00259-026-08116-6
BibTeX
@article{GarcaBelaustegui2026,
author = {García Belaustegui, Laura and de la Higuera López-Frías, Magdalena and de Abajo-Larriba, Jorge and Basanta Mota, Andrés and Bastidas, Juan Fernando and Morales Lozano, María Isabel and Grissanti, Fabiana and Arbizu, Javier},
title = {Comparative performance of 11C-methionine and 11C-choline PET/CT in primary hyperparathyroidism: Impact of adenoma weight on PET detectability},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {53},
number = {13},
pages = {7982--7991},
doi = {10.1007/s00259-026-08116-6}
}
EUVIMED